Sorafenib: a clinical and pharmacologic review

Author： Iyer Renuka   Fetterly Gerald   Lugade Amit   Thanavala Yasmin  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.11, Iss.11, 2010-08, pp. : 1943-1955

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Enoxaparin: a pharmacologic and clinical review

By Iqbal Zafar   Cohen Marc  

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 7, 2011-05 ,pp. : 1157-1170

Informa Healthcare

Access to resources Recommend Favorite

Rabeprazole: a pharmacologic and clinical review for acid-related disorders

By Dadabhai Alia   Friedenberg Frank K  

Expert Opinion on Drug Safety, Vol. 8, Iss. 1, 2009-01 ,pp. : 119-126

Informa Healthcare

Access to resources Recommend Favorite

Sorafenib (BAY 43-9006): Review of Clinical Development

By  

Current Clinical Pharmacology, Vol. 1, Iss. 3, 2006-01 ,pp. : 223-228

Bentham Science Publishers

Access to resources Recommend Favorite

Toxicity of sorafenib: clinical and molecular aspects

By Blanchet Benoit   Billemont Bertrand   Barete Stéphane   Garrigue Hélène   Cabanes Laure   Coriat Romain   Francès Camille   Knebelmann Bertrand   Goldwasser François  

Expert Opinion on Drug Safety, Vol. 9, Iss. 2, 2010-03 ,pp. : 275-287

Informa Healthcare

Access to resources Recommend Favorite

Topoisomerase I inhibition with topotecan: pharmacologic and clinical issues

By Arun B.   Frenkel E.P.  

Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 3, 2001-03 ,pp. : 491-505

Informa Healthcare

Access to resources Recommend Favorite